Primerica, Inc. current report, 05 May 2010

Primerica, Inc. Form 8-K Summary

Business Context and Reporting Period

Primerica, Inc. filed this Current Report on Form 8-K on May 5, 2010, to announce its results of operations for the quarter ended March 31, 2010. The filing includes a press release and supplemental financial information furnished to the SEC.

Key Financial Metrics

The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a notification of the results and a reference to the attached press release (Exhibit 99.1) and supplemental information (Exhibit 99.2) where these figures are detailed.

Material Changes and Non-GAAP Measures

The Company reports both GAAP and non-GAAP financial measures. The non-GAAP measures include pro forma operating revenues, pro forma operating income before income taxes, pro forma net operating income, and pro forma adjusted stockholders' equity. These measures exclude:

  • Realized investment gains and losses.
  • Equity award transactions related to the initial public offering.
  • Private equity sales by Citigroup Inc. to funds managed by Warburg Pincus LLC.
  • Unrealized investment gains and losses (for adjusted stockholders' equity).

Management excludes these items as they are considered unusual and not indicative of ongoing operations.

Guidance, Outlook, and Risks

The filing text does not contain specific forward-looking guidance, management commentary on future outlook, or a detailed discussion of risks and contingencies beyond the standard disclosure that non-GAAP measures have limitations and should not be viewed in isolation from GAAP results.

Investor Verification Checklist

  • Review Exhibit 99.1 (Press Release) for specific Q1 2010 revenue and earnings figures.
  • Examine Exhibit 99.2 for supplemental financial data and the reconciliation of GAAP to non-GAAP measures.
  • Verify the impact of realized and unrealized investment gains/losses on reported net income.
  • Confirm the treatment of equity award transactions and private equity sales in the pro forma calculations.